The continuous real-time 13C-octanoate breath test for patients with nonalcoholic steatohepatitis using the breathID system

Hepato-Gastroenterology

Volumn 56, Issue 94-95, 2009, Pages 1436-1438

  Mawatari, Hironori ^a   Inamori, Masahiko ^a   Fujita, Koji ^a   Yoneda, Masato ^a   Iida, Hiroshi ^a   Endo, Hiroki ^a   Hosono, Kunihiro ^a   Nozaki, Yuichi ^a   Yoneda, Kyoko ^a   Akiyama, Tomoyuki ^a   Takahashi, Hirokazu ^a   Goto, Ayumu ^a   Abe, Yasunobu ^a   Kirikoshi, Hiroyuki ^a   Kobayashi, Noritoshi ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Breath test; Mitochondrial beta oxidation; Nonalcoholic steatohepatitis

Indexed keywords

OCTANOIC ACID C 13; OCTANOIC ACID DERIVATIVE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FEMALE; HUMAN; INGESTION; LIVER MITOCHONDRION; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL;

ADULT; BREATH TESTS; CARBON ISOTOPES; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OCTANOIC ACIDS;

EID: 71949083682     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 221-231
2. Farrell GC: Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003; 18: 124-138
3. Diehl AM, Goodman Z, Ishak KG: Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-1062
4. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438 (Pubitemid 10057164)
5. Cadranel JF: Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future. Gastroenterol Clin Biol 2002; 26: 823-824
6. Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A: Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40: 371-378
7. Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A: High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007; 42: 573-582
8. Yoneda M, Mawatari H, Fujita K, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A: Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol 2007; 42: 375-381. (Pubitemid 47097254)
9. Yoneda M, Yoneda M, Fujita K, Inamori M, Tamano M, Hiriishi H, Nakajima A: Transient elastography in Patients with Nonalcoholic Fatty liver Disease (NAFLD). GUT 2008; 40: 371-378
10. Miele L, Grieco A, Armuzzi A, Candelli M, Forgione A, Gasbarrini A, Gasbarrini G: Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 2003; 98: 2335-2336 (Pubitemid 37305387)
11. Schneider AR, Kraut C, Lindenthal B, Braden B, Caspary WF, Stein J: Total body metabolism of 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men. Eur J Gastroenterol Hepatol 2005; 17: 1181-1184 (Pubitemid 41527434)
12. Yamanaka H, Inamori M, Fujisawa N, Akimoto K, Akiyama T, Fujita K, Takahashi H, Yoneda M, Abe Y, Kirikoshi H, Kubota K, Saito S, Ueno N, Nakajima A: Two Cases of Pyloduodenal Stenosis: The Efficiency of Gastric Emptying Evaluation Using 13C Continuous Breath Test (BreathID System) Digestion 2007; 20: 238.
13. Inamori M, Akiyama T, Akimoto K, Fujita K, Takahashi H, Yoneda M, Abe Y, Kubota K, Saito S, Ueno N, Nakajima A: Early effects of peppermint oil on gastric emptying: a crossover study using continuous real time 13C breath test (BreathID system) J Gastroenterol 2007; 42: 539-542.
14. Ikeda T, Inamori M, Fujisawa N, Iwasaki T, Akiyama T, Akimoto K, Mawatari H, Iida H, Endo H, Nozaki Y, Sakamoto Y, Fujita K, Takahashi H, Yoneda M, Yoneda K, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A: Effects of body positions on gastric emptying with enteral nutrition: a crossover study using a continuous real time 13C breath test (BreathID system). Hepatogastroenterology in press.
15. Shimoyama Y, Kusano M, Kawamura O, Zai H, Kuribayashi S, Higuchi T, Nagoshi A, Maeda M, Mori M: High-viscosity liquid meal accelerates gastric emptying. Neurogastroenterol Motil 2007; 19: 879-886 (Pubitemid 350060609)
16. Sanyal AJ: American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-1725
17. Ghoos YF, Maes BD, Geypens BJ, Mys G, Hiele MI, Rutgeerts PJ, Vantrappen G: Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104: 1640-7. (Pubitemid 23235453)
18. Anjiki H, Sanaka M, Kuyama Y: Dual effects of rabeprazole on solid-phase gastric emptying assessed by the 13C-octanoate breath test. Digestion 2005; 7: 189-194 (Pubitemid 41507279)
19. Sanaka M, Anjiki H, Tsutsumi H, Abe K, Kawakami T, Saitoh M, Yamamoto T, Ishii T, Kuyama Y: Effect of cigarette smoking on gastric emptying of solids in Japanese smokers: a crossover study using the 13C-octanoic acid breath test. J Gastroenterol 2005; 40: 578-582 (Pubitemid 41038786)
20. van de Casteele M, Luypaerts A, Geypens B, Fevery J, Ghoos Y, Nevens F: Oxidative breakdown of octanoic acid is maintained in patients with cirrhosis despite advanced disease. Neurogastroenterol Motil 2003; 15: 113-20. (Pubitemid 36532549)